Acutaas Chemicals Quarterly Results for Trading Insights

In Sept 2025, Acutaas Chemicals (ACUTAAS) reported revenue ₹316 Cr and net profit ₹72 Cr — revenue +23.9% YoY. For annual financials, live price and key ratios, visit ACUTAAS share price.

Latest Quarter Net Profit
₹72 Cr
QSept 2025
Quarterly Results

ACUTAAS Quarterly Results — Revenue, Profit & EPS Highlights

Acutaas Chemicals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with ACUTAAS fundamental valuation to assess whether the stock is under or overvalued.

  • Revenue of ₹316 Cr in Sept 2025 (+0.6% vs Mar 2025, +23.9% vs Sept 2024)
  • Net Profit of ₹72 Cr in Sept 2025 (+14.3% vs Mar 2025, +89.5% vs Sept 2024)
  • EBITDA of ₹105 Cr in Sept 2025 (+15.4% vs Mar 2025)
  • Operating Margin of 31.0% in Sept 2025 (+3.0pp vs Mar 2025)
  • Earnings Per Share of ₹8.82 in Sept 2025 (+13.1% vs Mar 2025)

Acutaas Chemicals Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ACUTAAS quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 316 314 223 398 255 0.6% 23.9%
Net Profit (₹ Cr) 72 63 44 106 38 - -
EBITDA (₹ Cr) 105 91 67 155 57 - -
EPS (₹) 8.82 7.80 5.41 13.19 9.38 - -
Operating Margin (%) 31.0% 28.0% 25.0% 38.0% 20.0% - -

ACUTAAS Share Price Trend — 1-Year Movement Across Quarterly Results

Acutaas Chemicals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse ACUTAAS ownership pattern to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 22.8%
EBITDA Margin 33.2%
Operating Margin 31.0%
ROE (Annual) 21.8%

Balance Sheet Highlights

Total Assets ₹1,549 Cr
Total Equity ₹1,320 Cr
Current Assets ₹792 Cr
Current Liabilities ₹27 Cr

Cash Flow Analysis

Operating Cash Flow ₹118 Cr
Investing Cash Flow ₹-224 Cr
Financing Cash Flow ₹261 Cr
Net Cash Flow ₹156 Cr

Current Market Data

Current Price ₹2467.80
Exchange NSE
Last Updated Apr 28, 2026

Revenue Trend (₹ Cr)

Dec 2025 398
Jun 2025 223
Mar 2025 314
Sept 2025 316

Net Profit Trend (₹ Cr)

Dec 2025 106
Jun 2025 44
Mar 2025 63
Sept 2025 72

Operating Margin Trend (%)

Dec 2025 38.0%
Jun 2025 25.0%
Mar 2025 28.0%
Sept 2025 31.0%

ACUTAAS vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Acutaas Chemicals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹415,924.72 Cr 1747.3 14,875 3,125 +10.8% - 21.0% 134.4
Divis Laboratories
Sept 2025 		₹171,625.44 Cr 6432.5 2,860 689 +7.1% - 24.1% 247.7
Torrent Pharmaceuti…
Sept 2025 		₹139,344.76 Cr 4182.9 3,219 591 +11.3% - 18.4% 238.5
Dr Reddys Laborator…
Sept 2025 		₹109,930.83 Cr 1354.6 9,135 1,337 +1.1% - 14.6% 83.7
Lupin
Sept 2025 		₹104,941.69 Cr 2302.7 6,921 1,485 +23.2% - 21.5% 71.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores